Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excision plus radiotherapy versus excision plus intralesional 5-fluorouracil for ear keloids
ACTRN12614000368639Phase 4Completed
- Sponsor
- Farrukh Aslam Khalid
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluorouracil in keloid (2 arms), sponsored by Farrukh Aslam Khalid. Primary endpoint: Recurrence of ear keloid. Started May 2014; status: completed.
02
Drugs
fluorouracil
03
Conditions
keloid
Beyond the preview
Go deeper on ACTRN12614000368639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000368639.